Index Venture Life Associates Vi LTD Centessa Pharmaceuticals PLC Transaction History
Index Venture Life Associates Vi LTD
- $131 Million
- Q2 2025
A detailed history of Index Venture Life Associates Vi LTD transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Index Venture Life Associates Vi LTD holds 9,961,789 shares of CNTA stock, worth $229 Million. This represents 100.0% of its overall portfolio holdings.
Number of Shares
9,961,789
Previous 9,961,789
-0.0%
Holding current value
$229 Million
Previous $143 Million
8.62%
% of portfolio
100.0%
Previous 100.0%
Shares
1 transactions
Others Institutions Holding CNTA
# of Institutions
127Shares Held
122MCall Options Held
638KPut Options Held
146K-
Medicxi Ventures Management (Jersey) LTD20MShares$459 Million74.33% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$223 Million4.43% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.4MShares$193 Million0.2% of portfolio
-
Janus Henderson Group PLC London, X06.53MShares$150 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.91MShares$136 Million0.01% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $2.17B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...